Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Seyna | 2025 | Venture - Series Unknown | $11.7M | Neuilly-sur-seine |
| Qbeast Analytics | 2025 | Seed | $7.6M | Bellevue |
| Rapydo | 2025 | Seed | $7.5M | New York |
| Moments Lab | 2025 | Venture - Series Unknown | $24.0M | Boulogne-billancourt |
| SeqOne Genomics | 2025 | Venture - Series Unknown | $22.6M | Montpellier |
| Azalea Vision | 2025 | Series A | $10.3M | Zwijnaarde |
| Zymvol Biomodeling | 2025 | Seed | $3.1M | Barcelona |
| Dunia Innovation | 2024 | Seed | $11.5M | Berlin |
| Qantev | 2024 | Series B | $33.5M | Paris |
| SURGAR | 2024 | Venture - Series Unknown | $12.3M | Clermont-ferrand |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Seyna | Venture - Series Unknown | $11.7M | Neuilly-sur-seine, France |
| 2 | Qbeast Analytics | Seed | $7.6M | Bellevue, United States |
| 3 | Rapydo | Seed | $7.5M | New York, United States |
| 4 | Moments Lab | Venture - Series Unknown | $24.0M | Boulogne-billancourt, France |
| 5 | SeqOne Genomics | Venture - Series Unknown | $22.6M | Montpellier, France |
| 6 | Azalea Vision | Series A | $10.3M | Zwijnaarde, Belgium |
| 7 | Zymvol Biomodeling | Seed | $3.1M | Barcelona, Spain |
| 8 | Dunia Innovation | Seed | $11.5M | Berlin, Germany |
| 9 | Qantev | Series B | $33.5M | Paris, France |
| 10 | SURGAR | Venture - Series Unknown | $12.3M | Clermont-ferrand, France |
Seyna is an insurance platform that builds a modern insurance ecosystem for brokers.
Unlock faster, more efficient analytics with Qbeast’s advanced multi-dimensional indexing and layout strategy
Rapydo provides a platform for real-time monitoring, query control, and automated optimization of MySQL and PostgreSQL databases.
Moments Lab develops AI technology for analyzing and organizing video content for media, sports, and brand organizations.
SeqOne is a next generation genomic analysis for next generation healthcare.
Azalea Vision is a medical manufacturer designing contact lenses with an active light management system for people with ocular disorders.
Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations.
Dunia Innovations is a Breakthrough materials for tomorrow's net zero planet.
AI claims platform for health & life insurance
SURGAR provides a plug-and-play augmented reality software suite for computer-aided laparoscopic surgery.
Doccla is the virtual ward company. We are the pioneers of tech-agnostic virtual wards.
Dottxt offers machine language models for information extraction and classification via API.
Continuity, uses AI to help insurances improve underwriting for SME's.
BIOPHTA has pioneered a novel approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery.
Intelligent Compute. Infinite Possibilities.
Digital wound care management
Mitiga Solutions provides climate risk intelligence that combines science, AI, and high-performance computing.
Vibe is a streaming TV advertising company for small and medium-sized businesses.
Hephaistos Pharma is a biotech company developing oncology treatments.
phospho is an AI startup that provides developers and businesses access to generative AI solutions.
i-Virtual develops an advanced AI-powered solution that enables touchless measurement of vital signs through a simple image or video capture
Tilak build a series of fun medical games to change the way we monitor chronic diseases.
HarfangLab develops a hunting software to boost detection and neutralization of cyberattacks against companies endpoints.
Nano Corp secures and monitors hybrid networks.
Developing healthy, natural, sustainable solutions to improve animal growth and nourish the planet
Elaia has invested in 109 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Elaia's top investment sectors include Software, Health Care, Artificial Intelligence (AI), Information Technology, Biotechnology. The firm invests across 44 different industry categories.
Among tracked funding rounds, Doccla received $46.0M in a Series B round. Elaia's total known invested capital is $1.1B.
Elaia's average investment size is $14.4M across its portfolio of 109 companies.
Recent Elaia portfolio additions include Seyna, Qbeast Analytics, Rapydo, Moments Lab, SeqOne Genomics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors